Elan to launch new painkiller in US

Irish pharmaceutical giant Elan aims to launch a new painkiller in the US early next year since reporting positive results from clinical trials of the product.

The group announced that its recent Phase III trial for Prialt met results in patients with severe chronic pain who had not achieved pain relief with other therapies, including intrathecally delivered morphine.